Announcements Trials
Browse Landscape

Status

Completed 8Unknown 6Terminated 1Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 63Observational 6

Sponsor

Cancer Type

Lymphoid 4Tumor-Agnostic 1Plasma cell 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3Recurrence 1Neoplasms 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1

Interventions

Blood Specimen Collection 85Surveys and Questionnaires 83Surgical Procedures, Operative 44Drug Therapy 32Radiotherapy 27Biopsy 26Amplified Fragment Length Polymorphism Analysis 24Neoadjuvant Therapy 23Immunohistochemistry 22Gene Expression Profiling 21Bevacizumab 19Data Collection 18Immunotherapy 17Ultrasonography 16Positron Emission Tomography Computed Tomography 16Magnetic Resonance Spectroscopy 16Liquid Biopsy 16pembrolizumab 15Nivolumab 15Watchful Waiting 14Radiosurgery 14Observation 14Microarray Analysis 14Magnetic Resonance Imaging 14Interviews as Topic 14Immune Checkpoint Inhibitors 13Colonoscopy 13Capecitabine 13Polymerase Chain Reaction 12Paclitaxel 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Observational × Lenalidomide × Clear all
NCT06251648 2024-02-09

Acute Lymphoblastic Leukaemia Related to Lenalidomide (LenALL)

University Hospital, Caen

Unknown
300 enrolled
Tumor-Agnostic

Neoplasms

NCT05923879 2023-06-28

Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma

Ruijin Hospital

Unknown
30 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05883709 2023-06-01

A Real-world Study of Tafasitamab in Combination With Lenalidomide in Patients withR/R DLBCL

Ruijin Hospital

Unknown
15 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05495620 2022-08-10

Long-term KRd in Relapsed and/or Refractory Multiple Myeloma

Dong-A University Hospital

Unknown
300 enrolled
Plasma cell

Multiple Myeloma

NCT04109872 2020-02-05

Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results.

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Unknown
25 enrolled
Lymphoid

Recurrence, Lymphoma, Mantle-Cell

NCT03715296 2019-07-08

Lenalidomide Based Immunotherapy in the Treatment of DLBCL

Ruijin Hospital

Unknown
200 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡